Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pyridazine compounds claimed by Biovitrum for diabetes Rx

April 26, 2002

Novavax withdraws NDA for Estrasorb with plans to resubmit

April 26, 2002

Takeda presents novel somatostatin receptor antagonists useful for diabetes and related disorders

April 25, 2002

Bayer seeks exclusive licensee for progestin agonist

April 25, 2002

Phase I/IIa trial initiated for TLK-199 in myelodysplastic syndrome

April 24, 2002

Preparation and use of PTP1B inhibitors described by Abbott

April 24, 2002

Ghrelin induces GH release and enhances cardiac performance in healthy humans

April 24, 2002

Patient treatment initiated in phase II trial of Aryplase in MPS VI

April 23, 2002

Potent and selective MC4 receptor agonists designed at Roche

April 23, 2002

Abbott reveals newly synthesized PTP1B inhibitors

April 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...